Xencor

XNCRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.871 B

$25.16 +0.52%

Close of 22 Sept 2026

Revenue

$125.6M

#2434 by revenue

Earnings

-$91.9M

Loss-making

Shares outstanding

74,353,397

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#117SepternaSEPN$1.88B
#118Stoke TherapeuticsSTOK$1.88B
#119XencorXNCR$1.87B
#120Ani PharmaceuticalsANIP$1.79B
#121NanobiotixNBTX$1.79B

What if Xencor were worth as much as…

Open the what-if tool →

Gold $30.2T

$406,625.26

Per share 16,162× higher

Bitcoin $1.74T

$23,424.01

Per share 931× higher

Nvidia $5.52T

$74,183.12

Per share 2,948× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Xencor are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.